| Size | Price | Stock | Qty |
|---|---|---|---|
| 100g |
|
||
| 500g |
|
||
| Other Sizes |
| Targets |
(1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide is not a drug and does not have a biological target. It is a chemical intermediate and a Wittig reagent. As a phosphonium salt, it is used in the Wittig reaction to convert carbonyl compounds (aldehydes, ketones) into alkenes. This reaction is fundamental in organic synthesis for the construction of C=C bonds in the synthesis of complex molecules, including pharmaceuticals and natural products. The compound is a tool for synthetic chemistry, not for biological modulation.
|
|---|---|
| ln Vitro |
(1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide has no direct in vitro biological activity. It is a chemical reagent used in test tubes for organic transformations. It is not used in cell-based assays. Any biological activity would be associated with the final products synthesized using this reagent, not the reagent itself. The compound is not cytotoxic at the low concentrations used in synthesis, but it is not a test article.
|
| ln Vivo |
(1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide is not used in vivo. It is a chemical intermediate, not a drug candidate. It has no therapeutic applications. It may be used in the synthesis of drugs that are later tested in animals, but the reagent itself is not administered. No in vivo studies are available. It is for research use only.
|
| Enzyme Assay |
(1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide is not used in cell-free biological assays. Its purity is assessed by HPLC or NMR. A typical protocol: dissolve the compound in DMSO-d6 for 1H NMR. Characteristic peaks: delta 7.7-7.9 (m, 15H, PPh3), 5.8 (m, 1H, CH), 4.2 (q, 2H, OCH2), 1.9 (d, 3H, CH3), 1.2 (t, 3H, CH3). 31P NMR: delta 21.5 (s). Purity >98%. The compound is a solid.
|
| Cell Assay |
(1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide is not used in cell culture experiments. It may be used as a synthetic intermediate for the preparation of compound libraries that are later tested in cells. For example, the compound can be used in a Wittig reaction to form an alkene, which can be further derivatized and tested for anti-cancer activity. The intermediate itself is not added to cells. No cellular assay data are available.
|
| Animal Protocol |
(1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide is not used in in vivo animal studies. It is a synthetic reagent. For a drug synthesized using this reagent, a typical in vivo protocol would involve administering the final compound to animals. However, the reagent itself is not used in such studies. No animal protocols are available.
|
| ADME/Pharmacokinetics |
Not applicable. (1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide (MW 457.32) is not a drug, and no PK data are available. It is soluble in DMSO and acetonitrile. For storage: powder at -20degC, protected from light and moisture. It is stable for at least 2 years under these conditions. For in vitro, dissolve in DMSO (50 mg/mL). Not for human use.
|
| Toxicity/Toxicokinetics |
(1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide may cause skin and eye irritation (H315, H319). It may be harmful if swallowed. The acute oral LD50 is not determined. Standard safety precautions: gloves, lab coat, safety glasses. Avoid inhalation of dust. Work in a fume hood. Not for human use. Dispose of according to local regulations.
|
| References | |
| Additional Infomation |
(1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide has CAS number 30018-16-7. Molecular formula C23H24BrO2P, MW 457.32. Also known as (1-Ethoxy-1-oxopropan-2-yl)triphenylphosphonium bromide, Wittig reagent. Research applications: organic synthesis, Wittig reaction, pharmaceutical intermediate. For research use only. Store at -20degC.
|
| Molecular Formula |
C23H24BRO2P
|
|---|---|
| Molecular Weight |
443.31
|
| Exact Mass |
442.07
|
| CAS # |
30018-16-7
|
| PubChem CID |
3084511
|
| Appearance |
White to off-white solid powder
|
| Hydrogen Bond Donor Count |
0
|
| Rotatable Bond Count |
7
|
| Heavy Atom Count |
27
|
| Complexity |
386
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CCOC(=O)C(C)[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3.[Br-]
|
| InChi Key |
RSYXORMKBUFAMS-UHFFFAOYSA-M
|
| InChi Code |
InChI=1S/C23H24O2P.BrH/c1-3-25-23(24)19(2)26(20-13-7-4-8-14-20,21-15-9-5-10-16-21)22-17-11-6-12-18-22;/h4-19H,3H2,1-2H3;1H/q+1;/p-1
|
| Chemical Name |
(1-ethoxy-1-oxopropan-2-yl)-triphenylphosphanium bromide
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.2558 mL | 11.2788 mL | 22.5576 mL | |
| 5 mM | 0.4512 mL | 2.2558 mL | 4.5115 mL | |
| 10 mM | 0.2256 mL | 1.1279 mL | 2.2558 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
